50 years of RNA @Yale a symposium in honor of Joan Steitz took place Aug. 19. All of us are grateful to Joan for her mentorship, friendship and leadership. Pic is of @NCISandraWolin and me in front, with Tom Cech's kick-off slide. Tx to @HaifanLin for pic. @YaleMBB@YaleGenetics
An 'antispacer' is an guide RNA spacer-targeted peptide nucleic acid used for #GeneRegulation of #CRISPR systems. Read more about this technique in @peterglazer's publication:
https://t.co/ASBQ2IlqVV #SCGE 🧬 @YaleMed
New research led by @economosn and @peterglazer in Nucleic Acids Research @NAR_Open reveals the creation of a next-generation #CRISPR precision tool to aid gene editing. @SmilowCancer@YaleMed@YNHH https://t.co/FZJODb37Fo
(1/x) Excited 2announce our most recent work on oncometabolites+DNA repair is out @nature today. A wonderful collaborative effort led by the Glazer & Bindra labs+many collaborators...here's the scoop @YaleCancer@YaleRadOnc @parkersulkowski @peterglazer
https://t.co/oPRh433hJM
Check out the power of combining PARP inhibitors with other chemo: Cybrexa scientific co-founder Peter Glazer, MD, PhD, is an author of a paper demonstrating potential synergy between PARP inhibitors and anti-angiogenic drugs
https://t.co/kfGiBDB3CA
#PARP#DDR#CancerResearch
New research @ScienceTM led by @peterglazer shows how a #cancer drug can help inhibit #DNA repair and one day boost the benefit of treatments for patients. @YaleMed@YNHH https://t.co/s1mLLjT0ax
About 18y ago I started my PhD in the Glazer Lab, and today our two labs publish a major paper together in Nature Genetics
https://t.co/jD3uzY5WZp
#instatweet
Studying two rare inherited cancer syndromes @YaleCancer scientists led by Dr. Peter Glazer have found #Cancers are driven by a breakdown in how cells repair their #DNA@NatureGenet https://t.co/kBvoALTsOk
2day,we publish part 2 of a wonderful @YaleCancer collaboration,establishing an entirely new pathway: TCA metabolites drive BRCAness, which can be exploited by PARPi's
@peterglazer@KidneyCancerDoc#openaccess below
IDH1/2:https://t.co/TZ5KdOQsMb
FH/SDH:https://t.co/EX6RoxUWWx
Thanks to Isabel Estrada-Portales of NHLBI for highlighting our work on gene editing for cystic fibrosis on the NHLBI website. The Egan, Saltzman and Glazer labs are working hard to advance this technology to help patients with CF. https://t.co/R4IQ91lMas
Huge congrats to lab member @AdeletheAdele for receiving the ‘Excellence in Research Award for Students and Fellows’ from the American Society of Gene and Cell Therapy! #sciencerockstar
#mdpimolecules Read the paper published by Prof. @peterglazer 's group from Yale University 'Peptide Nucleic Acids as a Tool for Site-Specific Gene Editing' https://t.co/H2vSZoaPsZ https://t.co/U9s7MGr05B